Lakeshore Hospital and Research Centre ()

110 +0 (0%) 1Y
Price per Unit 110
Minimum no. of Units 1000
Enter Units
Coupon Code
Get 1% OFF on a minimum share purchase of ₹1,00,000.

Use Code: UNLISTEDKRAFT
Investment Amount 0
Discount 0
Stamp Duty (0.015 %) 0
Final Amount 0
Unlisted shares

Lakeshore Hospital and Research Centre

DRHP Status : Not Filed

110

Current Price 110
Market Cap 1350 Cr
ISIN INE01TI01010
Face Value 10
P/E Ratio 30.8
EPS 4.39
P/B Ratio 3.4
Book Value 40
Debt to Equity Ratio 0
P&L Statement 2021 2022 2023 2024
Revenue 242 359 419 396
Cost of Material Consumed 70 102 112 111
Gross Margins 71.07 71.59 73.27 71.97
Change in Inventory -1 -2 -2 2
Employee Benefit Expenses 61 63 64 75
Other Expenses 80 113 143 135
EBITDA 32 83 102 73
OPM 13.22 23.12 24.34 18.43
Other Income 2 3 5 7
Finance Cost 4 2 2 1
D&A 20 22 23 24
EBIT 12 61 79 49
EBIT Margins 4.96 16.99 18.85 12.37
PBT 10 62 82 55
PBT Margins 4.13 17.27 19.57 13.89
Tax 2 18 25 11
PAT 8 44 57 44
NPM 3.31 12.26 13.6 11.11
EPS 0.8 4.4 5.7 4.4
Financial Ratios
 2021 2022 2023 2024
Operating Profit Margin 13.22 23.12 24.34 18.43
Net Profit Margin 3.31 12.26 13.6 11.11
Earning Per Share (Diluted) 0.8 4.4 5.7 4.4
Assets 2021 2022 2023 2024
Fixed Assets 337 340 328 347
CWIP 2 0 5 2
Investments 0 0 0 0
Trade Receivables 18 20 20 27
Inventory 9 11 13 11
Other Assets 61 93 134 121
Total Assets 427 464 500 508
Liabilities 2021 2022 2023 2024
Share Capital 100 100 100 100
FV 10 10 10 10
Reserves 195 231 273 300
Borrowings 38 19 13 0
Trade Payables 32 33 34 33
Other Liabilities 62 81 80 75
Total Liabilities 427 464 500 508
documents
documents
documents
documents
documents
Name Holding
Dr. Shamsheer Vayalil Parambath 42.60%
Mr. Yusuff Ali M A 18.80%
Other Investors 38.58%

Coming soon...

Coming soon...

Lakeshore Hospital & Research Centre Limited, a public, non-government company, is a leading multi-specialty hospital in Kerala, known for medical education, research, and patient-centered care, with its unlisted shares traded privately. 

Strengths:

  1. Consistent Financial Performance: In FY2023, the hospital reported a total operating income of ₹358.47 crore, a 17% increase from the previous year. The Profit Before Interest, Lease, Depreciation, and Tax (PBILDT) margin also improved to 24.43% from 22.88% in FY2022, indicating enhanced operational efficiency. ​

  2. Experienced Medical Team: The hospital employs 207 specialist doctors as full-time consultants, ensuring a high standard of medical care and a broad range of specialties. ​

  3. Diverse Medical Services: Offering services such as wireless capsule endoscopy, endoscopic ultrasonography, and double balloon enteroscopy, along with various organ transplantations, positions the hospital as a comprehensive healthcare provider in the region.

  4. Improved Liquidity Position: The current ratio, measuring the ability to cover short-term liabilities with short-term assets, improved from 1.19 in 2022 to 1.76 in 2023, suggesting better liquidity management.

Weaknesses:

  1. Dependence on Key Personnel: The hospital's reliance on its team of specialist doctors means that the departure of key medical staff could impact service delivery and patient trust.​

  2. Market Competition: The healthcare sector in India is highly competitive, with numerous hospitals offering similar services. Maintaining and enhancing patient inflow amidst such competition requires continuous investment in technology and quality care.​

  3. Regulatory Challenges: As with any healthcare institution, the hospital must navigate complex regulatory environments, which can impact operations and financial performance.​

  4. Liquidity Risk in Unlisted Shares: Investing in unlisted shares carries liquidity risks, as these shares are not traded on public stock exchanges, making it potentially challenging to find buyers when one wishes to sell.

Scroll Top ↑
unlistedkraft